This Apple-like Innovator is Revolutionizing Healthcare

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

Cynthia M. Friend net worth and biography

Cynthia Friend Biography and Net Worth

Director of Bruker

Dr. Friend has been a professor at Harvard University since 1982. She became the Theodore Williams Richards Professor of Chemistry in 1998 and a Professor of Materials Science in 2002. Dr. Friend has served in a variety of senior faculty and leadership roles at Harvard, including several advisory roles for the Dean of Faculty of Arts and Sciences and as Chair of the Harvard University Department of Chemistry and Chemical Biology from 2004 to 2007. From 2013 until 2019, Dr. Friend served as Director of the Rowland Institute at Harvard University, a non-profit organization whose goal is to support the high risk/high reward research of early career scientists. In 2020, Dr. Friend was named President and CEO of the Kavli Foundation, a philanthropic organization dedicated to advancing scientific causes for the public good. In 2014, she became Director of the Energy Frontier Research Center for Sustainable Catalysis at Harvard University, a Department of Energy-funded multi-institution effort focused on the design of efficient catalytic processes, where her responsibilities include management of the fiscal health of the Center and strategic scientific planning. Dr. Friend has received numerous awards for her scientific research and scholarship and has served on a number of research and scientific advisory boards and panels. Dr. Friend holds a Ph.D. in Chemistry from the University of California, Berkeley. Dr. Friend brings to the Board extensive technical expertise and significant experience in the investment strategy and infrastructure of academic as well as government research markets. Further, Dr. Friend has substantial management experience in non-profit scientific institutions and brings to the Board valuable insight into science policy and scientific research funding priorities. Dr. Friend serves on our Compensation Committee.

What is Cynthia M. Friend's net worth?: The estimated net worth of Cynthia M. Friend is at least $951,547.20 as of January 17th, 2023. Dr. Friend owns 11,576 shares of Bruker stock worth more than $951,547 as of April 25th. This net worth approximation does not reflect any other investments that Dr. Friend may own. Learn More about Cynthia M. Friend's net worth.
How do I contact Cynthia M. Friend?: The corporate mailing address for Dr. Friend and other Bruker executives is 40 Manning Road, Billerica MA, 01821. Bruker can also be reached via phone at (978) 663-3660 and via email at [email protected]. Learn More on Cynthia M. Friend's contact information.
Has Cynthia M. Friend been buying or selling shares of Bruker?: Cynthia M. Friend has not been actively trading shares of Bruker over the course of the past ninety days. Most recently, Cynthia M. Friend sold 921 shares of the business's stock in a transaction on Tuesday, January 17th. The shares were sold at an average price of $68.26, for a transaction totalling $62,867.46. Following the completion of the sale, the director now directly owns 11,576 shares of the company's stock, valued at $790,177.76. Learn More on Cynthia M. Friend's trading history.
Who are Bruker's active insiders?: Bruker's insider roster includes Cynthia Friend (Director), Gerald Herman (CFO), Marc Kastner (Director), Frank Laukien (CEO), Mark Munch (VP), and Richard Packer (Director). Learn More on Bruker's active insiders.
Are insiders buying or selling shares of Bruker?: In the last year, insiders at the medical research company sold shares 6 times. They sold a total of 255,437 shares worth more than $19,565,136.21. The most recent insider tranaction occured on March, 4th when Director Hermann Fritz Requardt sold 15,000 shares worth more than $1,350,900.00. Insiders at Bruker own 28.2% of the company. Learn More about insider trades at Bruker.
Information on this page was last updated on 3/4/2024.

Cynthia M. Friend Insider Trading History at Bruker

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/17/2023	Sell	921	$68.26	$62,867.46	11,576
3/22/2021	Sell	1,800	$60.43	$108,774.00	10,486
12/21/2020	Sell	1,800	$54.32	$97,776.00	9,184
12/15/2020	Sell	3,473	$54.95	$190,841.35	8,384
9/21/2020	Sell	800	$37.58	$30,064.00	12,657
6/22/2020	Sell	1,800	$40.57	$73,026.00	11,857

Cynthia M. Friend Buying and Selling Activity at Bruker

Bruker Company Overview

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Today's Range

Now: $80.46

$80.12

$81.50

50 Day Range

MA: $88.04

$77.76

$94.27

2 Week Range

Now: $80.46

$53.79

$94.86

Volume

213,128 shs

Average Volume

795,828 shs

Market Capitalization

$11.69 billion

P/E Ratio

27.55

Dividend Yield

0.24%

Beta

1.17